MPC Therapeutics: Funding, Investors & Team (Oct 2026)
MPC Therapeutics firmly believes that mitochondria, which are tiny cell organelles essential for metabolism, offer significant potential as therapeutic targets. Our startup, based in Switzerland, is dedicated to enhancing cell therapies and addressing degenerative diseases through cellular rejuvenation. Our unique strategy involves utilizing exclusive small molecules that directly target mitochondria and induce metabolic reprogramming. For additional information, please visit our website.
MPC Therapeutics has raised $110k across 1 funding round on record, the most recent an undisclosed round of $110k announced in Nov 2023.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
MPC Therapeutics Company Profile and Key Stats
Latest funding round on record: Nov 2023.
MPC Therapeutics Funding Rounds
MPC Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
MPC Therapeutics Funding Compared to Other Biotechnology Startups
MPC Therapeutics' latest round of $110k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like MPC Therapeutics in Biotechnology and Plan-les-ouates
Companies Similar to MPC Therapeutics
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
At Immitra Bio, we are developing a unique genetic medicine platform that combines two of the most powerful…
compliag is providing agile solutions for regulated industries, including the licencing, manufacturing and…
Isospec Analytics SA is a life science company that aims at simplifying molecular identification. We are…
MoonLake Immunotherapeutics is a biopharmaceutical company in the clinical stage that is developing new…
Cria Technologies reinvents cold-chain transport with high-vacuum insulation technology that offers…
Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections to…
AC Immune is a biopharmaceutical company based in Switzerland that is currently in the clinical stage. They…
AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at…
Combioxin SA is clinical-stage biotech company developing innovative anti-virulence drugs to treat severe…
MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat…
Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the…
MPC Therapeutics Funding FAQs
What does MPC Therapeutics do?
MPC Therapeutics firmly believes that mitochondria, which are tiny cell organelles essential for metabolism, offer significant potential as therapeutic targets. Our startup, based in Switzerland, is dedicated to enhancing cell therapies and addressing degenerative diseases through cellular rejuvenation. Our unique strategy involves utilizing exclusive small molecules that directly target mitochondria and induce metabolic reprogramming. For additional information, please visit our website.
How much funding has MPC Therapeutics raised?
MPC Therapeutics has raised $110k across 1 round on record. The most recent is an undisclosed round of $110k announced in Nov 2023.
When did MPC Therapeutics last raise funding?
MPC Therapeutics' most recent funding round on record is an undisclosed round of $110k, announced in Nov 2023.
Who founded MPC Therapeutics?
FundedIQ lists Augustin De Bettignies (Founder) at MPC Therapeutics.
Where is MPC Therapeutics headquartered?
MPC Therapeutics is based in Plan-les-ouates, Geneve, Switzerland.
How many employees does MPC Therapeutics have?
MPC Therapeutics is in the 1-10 employee band.
How does MPC Therapeutics' funding compare to other Biotechnology startups?
MPC Therapeutics' latest round of $110k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's MPC Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MPC Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.